Trademark Search in Canada

ACF AMINO ACIDS

View On IC.GC.CA

OPPOSED

on 29 Feb 2024

Last Applicant/ Owned by

PFANSTIEHL INC.

1219 Glen Rock AvenueWaukegan IL 60085

Serial Number

2074649 filed on 30^th Nov 2020

Correspondent Address

CABINET JURIDIQUE ST. LAWRENCE S.E.N.C.R.L.

2301, Saint-Patrick Street,Suite B6Montreal

QUÉBEC

H3K1B3

ACF AMINO ACIDS

Trademark usage description

chemical compositions, chemical additives and biochemical preparations for use in the formulation, development and manufacture of pharmaceuticals, bio Read More

Classification Information

Class [001]
Chemical compositions, chemical additives and biochemical preparations for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals and vaccines, sold exclusively to professionals in the pharmaceutical and biopharmaceutical industries; chemical compositions, chemical additives and biochemical preparations for use in biotechnological product development, namely, development of new or improved biologic products, and drug manufacturing processes, sold exclusively to professionals in the pharmaceutical and biopharmaceutical industries; chemical and biochemical excipient substances and active pharmaceutical ingredients for use in development, formulation and manufacture of pharmaceuticals, biopharmaceuticals and vaccines, sold exclusively to professionals in the pharmaceutical and biopharmaceutical industries; chemicals and biochemicals, namely carbohydrates, organic compounds, salts, stabilizing agents, catalysts, enzymes, active pharmaceutical ingredients, chemical and biochemical additives, drug delivery molecules and carrier substances and buffer compounds, all for use in the development, formulation and manufacture of pharmaceuticals and biopharmaceuticals and vaccines, sold exclusively to professionals in the pharmaceutical and biopharmaceutical industries; active chemical and biochemical pharmaceutical ingredients for use in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines, sold exclusively to professionals in the pharmaceutical and biopharmaceutical industries; pharmaceutical intermediates, namely chemical and biochemical substances acting as intermediates between the initial and final pharmaceutical product for use in the formulation, development and manufacture of pharmaceuticals and biopharmaceuticals, sold exclusively to professionals in the pharmaceutical and biopharmaceutical industries; biochemical excipients, namely biochemical binding substances, for use in the formulation, development and manufacture of pharmaceuticals and biopharmaceuticals, sold exclusively to professionals in the pharmaceutical and biopharmaceutical industries; biochemical catalysts, namely, biochemicals used to accelerate biological processes for use in the formulation, development and manufacture of pharmaceuticals and biopharmaceuticals, sold exclusively to professionals in the pharmaceutical and biopharmaceutical industries; biochemical preservatives for use in the formulation, development and manufacture of pharmaceuticals and biopharmaceuticals, sold exclusively to professionals in the pharmaceutical and biopharmaceutical industries.

Classification kind code

Class [042]
Biochemical research and development, chemical, biochemical and bacteriological research and analysis, research in the field of biology, pharmaceutical drug development services, product research and development, research and development in the pharmaceutical and biotechnology fields, research and development of vaccines and medicines, all of the foregoing services being provided exclusively to professionals in the pharmaceutical and biopharmaceutical industries.

Classification kind code

Mark Details

Serial Number

2074649

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 25^th Nov 2021	Agent Changed
Submitted for opposition 256 on 1^st Nov 2021	Notification of Possible Opposition Sent
Submitted for opposition 22 on 20^th Apr 2021	Search Recorded
Submitted for opposition 20 on 20^th Apr 2021	Examiner's First Report
Submitted for opposition 223 on 20^th Apr 2021	Total Provisional Refusal
Submitted for opposition 257 on 31^st Dec 2020	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 30^th Dec 2020	Formalized
Submitted for opposition 1 on 30^th Dec 2020	Created
Submitted for opposition 228 on 30^th Nov 2020	International Registration
Submitted for opposition 30 on 30^th Nov 2020	Filed